Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression (2015)
Attributed to:
cAMP phosphodiesterase-4: signalling complexes, regulation and potential therapeutic targets.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2015.335
Publication URI: http://dx.doi.org/10.1038/bjc.2015.335
Type: Journal Article/Review
Parent Publication: British Journal of Cancer
Issue: 10